Emosis Overview
- Founded
- 2015

- Status
- Private
- Latest Deal Type
- PE Growth
- Financing Rounds
- 3
- Investments
- 1
Emosis General Information
Description
Operator of a med tech company intended to address the largely unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases. The company specializes in the development and commercialization of in vitro diagnostic tests for hemostasis abnormalities that cause hemorrhagic or thromboembolic manifestations and also aims to inform physician medical decision with respect to bleeding or clotting events in a broad range of clinical settings, encompassing neurovascular diseases, cancer, pregnancy, and pharmacological and non-pharmacological therapy management.
Contact Information
- 11 rue de l'Industrie
- 67400 Illkirch-Graffenstaden
- France
Emosis Timeline
Emosis Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Emosis‘s full profile, request access.
Request a free trialEmosis Executive Team (6)
Emosis Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
000 0'00000 00.0 | Self | Chairman & Co-Founder | 000 0000 |
0000000 0000000-000000 00.0 | Self | Board Member | 000 0000 |
0000-0000ç000 000 | Capital Grand Est | Board Member | 000 0000 |
0000-0000 0000 | Emosis | Board Member | 000 0000 |
0000000 00000 | Self | Board Member | 000 0000 |
Emosis Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Emosis‘s full profile, request access.
Request a free trialEmosis Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 | 06-Dec-2018 | 00000 0000000 | Diagnostic Equipment | 00é0é000 00000000 00 |